Results 51 to 60 of about 70,766 (259)
The characteristics of collagen‐induced rheumatoid arthritis in macaques and the changes of heart
The disease progression in CIA macaques was categorized into three stages: IIR (days 14–34): The indicators related to rheumatoid arthritis and the levels of immunoglobulin were all elevated. There was a small amount of joint effusion, edema and mild synovial hyperplasia. No joint swelling was observed by naked eye.
Lei Zhang +8 more
wiley +1 more source
Update on Transcatheter Tricuspid Valve Replacement Therapies
Severe tricuspid regurgitation is relatively common, especially in the elderly, and portends poor survival. Neither medical therapy nor conventional surgery is efficacious for most patients.
Ythan H. Goldberg +3 more
doaj +1 more source
ABSTRACT Background The optimal choice between balloon‐expandable (BE) and self‐expanding (SE) transcatheter heart valves (THVs) in patients with low‐flow low‐gradient aortic stenosis (LFLG AS) undergoing transcatheter aortic valve replacement (TAVR) remains unclear.
Nav Warraich +10 more
wiley +1 more source
ABSTRACT Background Prosthesis‐patient mismatch (PPM) remains common following transcatheter aortic valve replacement (TAVR) and is associated with worse clinical outcomes. PPM is of particular concern in small aortic annuli (SAA). Aims To compare the incidence, predictors, and long‐term impact of PPM in SAA TAVR.
Itamar Loewenstein +9 more
wiley +1 more source
Transcatheter Tricuspid Valve Interventions to Manage Tricuspid Regurgitation: A Narrative Review
Medical devices for tricuspid regurgitation have emerged as viable treatment options for patients who do not respond to drug therapy or who are unsuitable for open-heart surgery due to high surgical risk.
Sara Veneziano +4 more
doaj +1 more source
Transcatheter tricuspid valve interventions: Current status and future perspectives
The development of transcatheter therapies to treat valvular heart diseases has changed the rules of the game, particularly in the case of aortic stenosis and mitral regurgitation.
Alberto Alperi +21 more
doaj +1 more source
ABSTRACT Background Mitral regurgitation (MR) is the valent type of valvular heart disease, caused by primary leaflet lesions or annular dilatation secondary to left ventricular dysfunction. It can lead to a series of complications such as volume overload, exacerbated pulmonary congestion, and heart failure, significantly impacting patient prognosis ...
Juelian Li +4 more
wiley +1 more source
ABSTRACT Background Advanced heart failure (HF) remains a clinical challenge, and mitral transcatheter edge‐to‐edge repair (M‐TEER) has emerged as a potential bridging strategy. Aims To describe the clinical outcomes of M‐TEER in a single‐center cohort of patients with advanced HF and to identify anatomical and clinical features potentially associated ...
Pedro Castilhos de Freitas Crivelaro +8 more
wiley +1 more source
Spurious tricuspid regurgitation: Three conditions mimicking tricuspid regurgitation diagnosed at operation [PDF]
Brown, A. H., and Braimbridge, M. V. (1973). Thorax , 28 , 495-497. Spurious tricuspid regurgitation: Three conditions mimicking tricuspid regurgitation diagnosed at operation. The diagnosis of tricuspid incompetence is difficult. Three patients are described in whom the diagnosis of tricuspid regurgitation was made but disproved by the findings at
A H, Brown, M V, Braimbridge
openaire +2 more sources
ABSTRACT This patient is a 77‐year‐old male with non‐ischemic cardiomyopathy, severe tricuspid regurgitation, and moderate mitral regurgitation who underwent simultaneous transcatheter edge‐to‐edge repair of both mitral and tricuspid valves. Post‐procedure, the patient exhibited significant symptomatic improvement and reduced regurgitation severity ...
Omar Khan, Matthew Summers
wiley +1 more source

